Showing 1 - 10 results of 10 for search 'Qi-jing Wang', query time: 0.07s
Refine Results
-
1
-
2
Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer by Qiu‐Zhong Pan, Jia‐Mei Gu, Jing‐Jing Zhao, Yan Tang, Qi‐Jing Wang, Qian Zhu, Meng‐Jia Song, Yong‐Qiang Li, Jia He, Shi‐Ping Chen, De‐Sheng Weng, Jian‐Chuan Xia
Published 2020-01-01
Article -
3
Decreased expression of the FOXO3a gene is associated with poor prognosis in primary gastric adenocarcinoma patients. by Xiao-bo Yang, Jing-jing Zhao, Chun-yu Huang, Qi-jing Wang, Ke Pan, Dan-dan Wang, Qiu-zhong Pan, Shan-shan Jiang, Lin Lv, Xiang Gao, Huang-wei Chen, Jia-yin Yao, Min Zhi, Jian-chuan Xia
Published 2013-01-01
Article -
4
Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer. by Dan-dan Wang, Yi-bing Chen, Ke Pan, Wei Wang, Shi-ping Chen, Ju-gao Chen, Jing-jing Zhao, Lin Lv, Qiu-zhong Pan, Yong-qiang Li, Qi-jing Wang, Li-Xi Huang, Miao-la Ke, Jia He, Jian-Chuan Xia
Published 2012-01-01
Article -
5
Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection by Qiu-Zhong Pan, Jing-Jing Zhao, Chao-Pin Yang, Yu-Qing Zhou, Jun-Zhong Lin, Yan Tang, Jia-Mei Gu, Qi-Jing Wang, Yong-Qiang Li, Jia He, Shi-Ping Chen, Meng-Jia Song, Yue Huang, Jie-Ying Yang, De-Sheng Weng, Jian-Chuan Xia
Published 2020-01-01
Article -
6
Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patients. by Yan Zheng, Dan-dan Wang, Wei Wang, Ke Pan, Chun-yu Huang, Yuan-fang Li, Qi-jing Wang, Shu-qiang Yuan, Shan-shan Jiang, Hai-bo Qiu, Yong-ming Chen, Xiao-fei Zhang, Bai-wei Zhao, Cong Mai, Jian-chuan Xia, Zhi-wei Zhou
Published 2014-01-01
Article -
7
Intratumoral Expression of IL-17 and Its Prognostic Role in Gastric Adenocarcinoma Patients by Ju-gao Chen, Jian-chuan Xia, Xiao-ting Liang, Ke Pan, Wei Wang, Lin Lv, Jing-jing Zhao, Qi-jing Wang, Yong-qiang Li, Shi-ping Chen, Jia He, Li-xi Huang, Miao-la Ke, Yi-bing Chen, Hai-qing Ma, Zhen-wu Zeng, Zhi-wei Zhou, Alfred E Chang, Qiao Li
Published 2011-01-01
Article -
8
Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors by Chang-Long Chen, Qiu-Zhong Pan, De-Sheng Weng, Chuan-Miao Xie, Jing-Jing Zhao, Min-Shan Chen, Rui-Qing Peng, Dan-Dan Li, Ying Wang, Yan Tang, Qi-Jing Wang, Zhi-Ling Zhang, Xiao-Fei Zhang, Li-Juan Jiang, Zi-Qi Zhou, Qian Zhu, Jia He, Yuan Liu, Fang-Jian Zhou, Jian-Chuan Xia
Published 2018-04-01
Article -
9
The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 s... by Meng‐Jia Song, Qiu‐Zhong Pan, Ya Ding, Jianxiong Zeng, Pei Dong, Jing‐Jing Zhao, Yan Tang, Jingjing Li, Zhiling Zhang, Junyi He, Jieying Yang, Yue Huang, Ruiqing Peng, Qi‐Jing Wang, Jia‐Mei Gu, Jia He, Yong‐Qiang Li, Shi‐Ping Chen, Rongxing Huang, Zi‐Qi Zhou, Chaopin Yang, Yulong Han, Hao Chen, Heping Liu, Shangzhou Xia, Yang Wan, De‐Sheng Weng, Liming Xia, Fang‐Jian Zhou, Jian‐Chuan Xia
Published 2021-01-01
Article -
10
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated met... by Qiu-Zhong Pan, Jing-Jing Zhao, Liang Liu, Dong-Sheng Zhang, Li-Ping Wang, Wen-Wei Hu, De-Sheng Weng, Xiang Xu, Yi-Zhuo Li, Yan Tang, Wei-Hong Zhang, Jie-Yao Li, Xiao Zheng, Qi-Jing Wang, Yong-Qiang Li, Tong Xiang, Li Zhou, Shuang-Ning Yang, Chen Wu, Rong-Xing Huang, Jia He, Wei-Jiao Du, Lu-Jun Chen, Yue-Na Wu, Bin Xu, Qiong Shen, Yi Zhang, Jing-Ting Jiang, Xiu-Bao Ren, Jian-Chuan Xia
Published 2024-04-01
Article